АктуалноБългарияВластЖивотИзбориИзпод тепетоМненияНовиниПод лупа

Подписката за достъпен транспорт в селата около Пловдив вече е в Парламента

Павел Михайлов внесе подписка, подкрепена от над 2000 души-жители на Родопската яка, с настояване за промени в Закона за автомобилните превози, които да решат транспортната криза в Родопската яка

Кметът на община Родопи Павел Михайлов внесе в Народното събрание подписката за достъпен транспорт, подкрепена от над 2100 жители на общината. Припомняме, че преди 10 дни той инициира подписка за промяна в закона, която да улесни транспорта между община „Родопи“ и областния град Пловдив. Документът беше предаден лично на Кирил Добрев, председател на Комисията по транспорт и съобщения, с настояване за законодателни промени в Закона за автомобилните превози. Михайлов бе придружен от секретаря на общината Иванка Петкова и народния представител от 17-ти МИР Пловдив област – Галин Дулев.

Подписката съдържа искане да отпадне задължителното ползване на автогара като крайна и начална спирка по маршрутните разписания. Вместо това, автобусите по междуселищните линии да могат да се движат по маршрутите на градския транспорт, използвайки съществуващите спирки. По думите му, идеята е обсъждана вече шест години и е подкрепена от редица институции, сред които Министерството на транспорта, Областна управа и Община Пловдив.

Разчитам на заявеното съдействие и ангажираност от г-н Добрев за решаване на този социален проблем за Община Родопи. Убеден съм, че има воля и единомислие както от държавните институции, така и от местната власт“, коментира кметът.

Според него, промяната е наложителна, тъй като сегашната регулация прави пътуването между селата и Пловдив трудно, скъпо и неудобно, особено за ученици, възрастни хора и работещи. Целта е междуселищните автобуси да имат по-гъвкави маршрути, които да осигурят достъпна и безопасна връзка с града.

Надявам се заедно да покажем, че здравето, безопасността и социалното благосъстояние на хората са наш приоритет“, добави Михайлов.

Очаква се темата да влезе в дневния ред на законодателните промени.

Припомняме, че проблеми с транспротната свързаност с Пловдив имат и селата от Община Марица. Днес от 18:00 часа в Народно читалище „Светлина“ в село Труд ще се проведе среща между жителите на населеното място, превозвача Петко Ангелов, кмета на община Марица Димитър Иванов и кмета на селото Спас Стайков.

Таня Грозданова

Журналист с близо 30 години опит, който работи интензивно по… More »

11 коментари

  1. The statements and the merchandise of this company aren’t supposed to
    diagnose, deal with, remedy or prevent any disease.PeptideGurus is a chemical supplier.
    PeptideGurus is not a compounding pharmacy or chemical compounding facility as defined under
    503A of the Federal Food, Drug, and Beauty act. Peptide Sciences is not an outsourcing facility as outlined beneath
    503B of the Federal Meals, Drug, and Beauty act.
    What’s actually interesting is how the anti-inflammatory effects have an extremely broad spectrum.

    „… the broad anti‐inflammatory impact will not lead to robust immunosuppression as seen with the corticosteroids or systemic calcineurin inhibitors. The good news is KPV was determined to be the „minimum effective sequence“ needed for α-MSH to exert its inflammation-lowering properties. Get ready to find a model new Golden Age therapy very few peptide physicians even find out about in 2021.
    The peptide’s interplay with melanocortin receptors triggers cascading effects that stretch beyond simple receptor activation. Recent analysis indicates that the compound influences epigenetic modifications, leading to sustained anti-inflammatory gene expression patterns. This mechanism explains the peptide’s capacity to produce long-lasting therapeutic effects even after remedy discontinuation. As your body’s pure response to hurt from damage or sickness, irritation is important for initiating the therapeutic process. → Melanocortin receptor activityKPV is believed to act primarily through MC1R and MC3R receptors, which are expressed on immune cells and tissues concerned in irritation.
    When researchers need to purchase KPV capsules for research, supplier choice is vital to ensure analysis high quality and regulatory compliance. The Genemedics Institute has compiled 97 studies about KPV and lots of of its other potential advantages (based on being derived from α-MSH) that embrace protecting in opposition to stroke and nerve injury. In Contrast To other therapeutic peptides that are likely to exist solely in a single formulation, KPV could be administered in three different ways. Intriguingly, we found that HA-KPV-NPs exert combined results towards UC by both accelerating mucosal healing and alleviating irritation. Sadly, the only study I might find instantly utilizing KPV involved treating a selected type of IBD known as ulcerative colitis. Moreover, a lot of KPV’s well being advantages are derived from what is known about its precursor α-MSH.
    By using these targeted delivery strategies, you presumably can amplify the therapeutic potential of KPV Peptide, offering promising outcomes for a selection of health circumstances. It has been found that KPV Peptide can successfully modulate the secretion of pro-inflammatory cytokines, which play a significant role within the inflammatory alterations seen in IBD. Research have proven that this peptide therapy can enhance the restore of broken mucosal tissues throughout the colon, leading to improved clinical outcomes for individuals suffering from IBD. The capacity of KPV Peptide to influence various mobile processes, corresponding to apoptosis and cell proliferation, further underscores its potential as a useful tool within the management of IBD. The GLOW peptide protocol offers a science-based method to pores and skin rejuvenation and tissue repair via the mixed motion of BPC-157, TB-500, and GHK-Cu. These three peptides work together to stimulate collagen production, speed up wound therapeutic, reduce irritation, and enhance radiant pores and skin appearance. One of probably the most compelling attributes of KPV peptide is its potent anti‑inflammatory exercise.
    At its core, Kpv peptide is acknowledged for its role in modulating inflammatory responses throughout the skin. By interacting with specific mobile pathways, Kpv peptide could help to dampen inflammatory indicators, thereby supporting a healthier mobile environment. This makes it a useful element in formulations designed to handle sensitive skin, redness, and irritation. In conclusion, the science behind KPV peptide reveals a potent and multi-faceted anti-inflammatory agent. Its intracellular mechanisms, capability to modulate immune responses, and synergistic antimicrobial results make it a promising compound for treating a variety of inflammatory conditions.
    Peptide Sciences provides a higher-dose KPV product, appropriate for these needing extra intensive treatment for persistent irritation. When it involves administering KPV peptide, the right dosage is crucial for reaching optimum results, depending on the condition being handled. KPV peptide could be administered in various varieties, including orally, topically, or through injections, each with its personal dosage suggestions. However, as with any peptide remedy, it’s important to use KPV peptide under the supervision of a qualified healthcare supplier to ensure the appropriate dosage and method of administration during KPV uptake. KPV peptide is versatile by means of its administration, making it accessible for varied forms of therapy protocols. Relying on the condition being treated, KPV peptide could be administered orally, topically, or through injections.
    We subsequently investigated whether or not KPV may be transported by hPepT1 into Caco2-BBE cells. We first assessed the inhibitory impact of KPV vs Gly-Leu on hPepT1-mediated transport of [14C]Glycine-Sarcosine (Gly-Sar) which is a generally used hPepT1 substrate. One hundred μM KPV inhibited [14C]Gly-Sar uptake more effectively than one hundred μM Gly-Leu (~45% inhibition by KPV vs ~25% by Gly-Leu) (Figure 4A). To further affirm that hPepT1 transports KPV, uptake experiments have been carried out using [3H]KPV.

    References:

    git.hundseth.com

Вашият коментар

Back to top button
Изпрати новина